Buyon, J P <br/><br/>
Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus.  [electronic resource] 

 -  Clinical immunology and immunopathology  Jan 1988 
 - 141-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0090-1229 
<br/><br/><label>Standard No.: </label>10.1016/0090-1229(88)90014-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--immunology<br/>Complement C3--analogs & derivatives<br/>Complement C3a--analogs & derivatives<br/>Humans<br/>Lupus Erythematosus, Systemic--immunology<br/>Neutrophils--analysis<br/>Receptors, Complement--analysis<br/>Receptors, Complement 3b